Autolus Therapeutics plc (AUTL)
NASDAQ·Healthcare·Biotechnology
$1.45
-0.34%
Mkt Cap $431.15M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (4 analysts)
$8.87
Range $7.60 – $11.00
Implied Upside
+513.8%
Consensus $8.87 vs current $1.45
NASDAQ·Healthcare·Biotechnology
$1.45
-0.34%
Mkt Cap $431.15M
Buy
4
Hold
0
Sell
0
Price Target (4 analysts)
$8.87
Range $7.60 – $11.00
+513.8%
Consensus $8.87 vs current $1.45